Last updated: 17 August 2019 at 4:12am EST

Jeffrey S Sherman Net Worth

The estimated Net Worth of Jeffrey S Sherman is at least $25 Milhão dollars as of 25 May 2017. Jeffrey Sherman owns over 48,727 units of Becton Dickinson & Co stock worth over $16,550,159 and over the last 21 years Jeffrey sold BDX stock worth over $8,429,314.

Jeffrey Sherman BDX stock SEC Form 4 insiders trading

Jeffrey has made over 35 trades of the Becton Dickinson & Co stock since 2007, according to the Form 4 filled with the SEC. Most recently Jeffrey exercised 48,727 units of BDX stock worth $3,712,023 on 25 May 2017.

The largest trade Jeffrey's ever made was exercising 63,200 units of Becton Dickinson & Co stock on 17 May 2016 worth over $4,817,104. On average, Jeffrey trades about 8,082 units every 46 days since 2004. As of 25 May 2017 Jeffrey still owns at least 70,821 units of Becton Dickinson & Co stock.

You can see the complete history of Jeffrey Sherman stock trades at the bottom of the page.

What's Jeffrey Sherman's mailing address?

Jeffrey's mailing address filed with the SEC is C/O BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES, NJ, 07417.

Insiders trading at Becton Dickinson & Co

Over the last 22 years, insiders at Becton Dickinson & Co have traded over $106,782,599 worth of Becton Dickinson & Co stock and bought 23,860 units worth $1,771,828 . The most active insiders traders include Edward J Ludwig, William M Brown, eVincent A Forlenza. On average, Becton Dickinson & Co executives and independent directors trade stock every 20 days with the average trade being worth of $4,349,205. The most recent stock trade was executed by Roland Goette on 14 August 2024, trading 5,295 units of BDX stock currently worth $701,799.

What does Becton Dickinson & Co do?

Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others.

Complete history of Jeffrey Sherman stock trades at Becton Dickinson & Co

Acionista maioritário	Trans. Transação	Preço total
Jeffrey S Sherman Vice Presidente e Conselho Geral	Exercício de opção	$3,712,023 25 May 2017
Jeffrey S Sherman Vice Presidente e Conselho Geral	Exercício de opção	$3,199,532 15 Feb 2017
Jeffrey S Sherman Vice Presidente e Conselho Geral	Exercício de opção	$3,199,532 15 Feb 2017
Jeffrey S Sherman Vice Presidente e Conselho Geral	Exercício de opção	$4,817,104 17 May 2016
Jeffrey S Sherman Vice Presidente e Conselho Geral	Venda	$1,166,423 7 Dec 2015
Jeffrey S Sherman Vice Presidente e Conselho Geral	Exercício de opção	$1,044,005 13 May 2015
Jeffrey S Sherman Vice Presidente e Conselho Geral	Exercício de opção	$1,025,500 9 Jun 2014
Jeffrey S Sherman Vice Presidente e Conselho Geral	Venda	$150,053 6 Mar 2014
Jeffrey S Sherman Vice Presidente e Conselho Geral	Exercício de opção	$915,793 11 Nov 2013
Jeffrey S Sherman Vice Presidente e Conselho Geral	Exercício de opção	$888,406 7 May 2013
Jeffrey S Sherman Vice Presidente e Conselho Geral	Exercício de opção	$886,937 7 Feb 2013
Jeffrey S Sherman Vice Presidente e Conselho Geral	Venda	$1,681,279 3 Aug 2012
Jeffrey S Sherman Vice Presidente e Conselho Geral	Venda	$91,907 9 Dec 2010
Jeffrey S Sherman Vice Presidente e Conselho Geral	Exercício de opção	$1,042,991 2 Dec 2010
Jeffrey S Sherman Vice Presidente e Conselho Geral	Venda	$148,849 29 Jan 2010
Jeffrey S Sherman Vice Presidente e Conselho Geral	Venda	$266,406 5 Feb 2009
Jeffrey S Sherman Vice Presidente e Conselho Geral	Venda	$464,813 10 Dec 2007
Jeffrey S Sherman Vice Presidente e Conselho Geral	Venda	$244,927 27 Mar 2007

Becton Dickinson & Co executives and stock owners

Becton Dickinson & Co executives and other stock owners filed with the SEC include:

Vincent Forlenza,
Executive Chairman of the Board
Patrick Kaltenbach,
Executive Vice President, President - Life Sciences
Thomas Polen,
President, Chief Executive Officer, Chief Operating Officer, Director
Christopher Reidy,
Chief Financial Officer, Executive Vice President, Chief Administrative Officer
Alberto Mas,
Executive Vice President, President - Medical Segment
Thomas E. Polen Jr.,
Pres, CEO & Chairman
Samrat Khichi,
Executive Vice President - Public Policy and Regulatory Affairs
Alexandre Conroy,
Executive Vice President, Chief Integrated Supply Chain Officer
Vincent A. Forlenza,
Exec. Chairman
Samrat S. Khichi,
Exec. VP of Regulatory & Gov. Affairs and Gen. Counsel
Alberto Mas,
Exec. VP & Pres of the Medical Segment
Samrat S. Khichi Esq.,
Exec. VP of Corp. Devel., Public Policy & Regulatory Affairs and Gen. Counsel
Christopher R. Reidy,
Exec. VP, CFO & Chief Admin. Officer
Simon D. Campion,
Exec. VP & Pres of Interventional Segment
Christopher DelOrefice,
Exec. VP & CFO
Marshall Larsen,
Lead Independent Director
Bertram Scott,
Independent Director
Claire Fraser,
Independent Director
Christopher Jones,
Independent Director
Catherine Burzik,
Independent Director
Claire Pomeroy,
Independent Director
Timothy Ring,
Independent Director
Rebecca Rimel,
Independent Director
David Melcher,
Independent Director
Jeffrey Henderson,
Independent Director
R. Andrew Eckert,
Independent Director
John DeFord,
Executive Vice President, Chief Technology Officer
James Lim,
Executive Vice President, President, Greater Asia
Thomas Spoerel,
Chief Accounting Officer, Principal Accounting Officer, Vice President, Controller
Monique Dolecki,
Investor Relations Contact Officer
Charles Bodner,
Senior Vice President, Corporate Finance
Roland Goette,
Executive Vice President, President - EMEA
Simon Campion,
Executive Vice President and President, BD Interventional Segment
Betty Larson,
Executive Vice President- Human Resources, Chief Human Resources
Denise Fleming,
Exec. VP of Technology & Global Services and Chief Information Officer
Francesca M. DeMartino,
Sr. VP of Investor Relations
Dr. Joseph M. Smith F.A.C.C, M.D., Ph.D.,
Sr. VP, Chief Scientific Officer & Co-Chair of Scientific Advisory Board
Troy Kirkpatrick,
VP of PR
Elizabeth McCombs,
Exec. VP & Chief Technology Officer
Michelle Quinn,
Sr. VP and Chief Ethics & Compliance Officer
Jerry Flasz,
Exec. VP of Global Services & Chief Information Officer
Dr. John A. DeFord,
Exec. VP of R&D and CTO
Thomas J. Spoerel,
Sr. VP, Controller & Chief Accounting Officer
Joanne Waldstreicher,
Director
Gary A Mecklenburg,
Director
John E Gallagher,
VP, Corp Finance and Treasurer
Linda M Tharby,
Segment Pres. Life Sciences
Wilard J Jr Overlock,
Director
Nabil Shabshab,
Senior Vice President
Jeffrey S Sherman,
VP and General Counsel
Basil Anderson,
Director
Ellen R Strahlman,
Senior Vice President
James F Orr,
Director
William A Tozzi,
VP and Controller
Gary M Cohen,
President - BD Medical Systems
Stephen Sichak,
Senior Vice President
Henry P Jr Becton,
Director
Carrie L Byington,
Director
Edward Degraan,
Director
William A Kozy,
Pres - BD CLS and Cmpy Oper
Alfred Sommer,
Director
David Shan,
EVP and Chief ISC Officer
Shana Carol Neal,
EVP and Chief People Officer
John P Groetelaars,
EVP
James W Borzi,
EVP & Chief Supply Chain Offcr
Suketu Upadhyay,
Senior VP and Controller
Adel Mahmoud,
Director
Jerome V Hurwitz,
Senior Vice President
Donna M Boles,
Sr. Exec VP - Human Resources
David V Elkins,
Executive VP and CFO
David T Durack,
Senior Vice President
William E. Rhodes,
Senior Vice President
Joseph Mercurio,
VP and Corporate Controller
Patricia B Shrader,
Senior Vice President
Scott P Bruder,
SrVP; Chief Technology Officer
Cathy E. Minehan,
Director
Margeretha Af Ugglas,
Director
Edward J Ludwig,
Chairman, President and CEO
James E Perrella,
Director
Alfred John Hanson,
Executive Vice President
John R Considine,
Executive VP and CFO
Jean Marc Dageville,
VP - Human Resources
Harry N Beaty,
Director
Frank Albert Olson,
Director
Bridget M Healy,
VP, Gen Counsel and Secy
Christopher Del Orefice,
EVP & Chief Financial Officer
Antoine C Ezell,
EVP, President NA & CMO
David Hickey,
EVP & President, Life Sciences
William M Brown,
Director
Rishi Grover,
EVP and Chief ISC Officer
Michael David Garrison,
EVP & President Medical
Richard Byrd,
EVP & President Interventional
Pavan Kumar Mocherla,
EVP & President Greater Asia
Michael Feld,
EVP & President, Life Sciences